Transcriptomic analysis and machine-learning models enable patient stratification, allowing for the identification of biomarkers such as ADAM8, CD47, BATF, SELE, IL-37 that may aid in diagnosis and differentiating ACD from other forms of dermatitis (2). Here, CD47 is linked to granular corneal dystrophy type II.